Journal of Heart and Lung Transplantation最新文献

筛选
英文 中文
Periodic administration of levosimendan as a bridge to transplant : Potiusque sero quam nunquam. 定期服用左西孟旦作为移植的桥梁 Potiusque Sero Quam Nunquam.
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-11-06 DOI: 10.1016/j.healun.2024.10.031
Daniele Masarone, Luigi Falco, Angelo Caiazzo, Claudio Marra, Emilio di Lorenzo
{"title":"Periodic administration of levosimendan as a bridge to transplant : Potiusque sero quam nunquam.","authors":"Daniele Masarone, Luigi Falco, Angelo Caiazzo, Claudio Marra, Emilio di Lorenzo","doi":"10.1016/j.healun.2024.10.031","DOIUrl":"10.1016/j.healun.2024.10.031","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long short-term memory algorithm for personalized tacrolimus dosing: A simple and effective time series forecasting approach post-lung transplantation. 个性化他克莫司剂量的长短期记忆算法:肺移植术后简单有效的时间序列预测方法。
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-11-05 DOI: 10.1016/j.healun.2024.10.026
Haruki Choshi, Kentaroh Miyoshi, Maki Tanioka, Hayato Arai, Shin Tanaka, Kazuhiko Shien, Ken Suzawa, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka
{"title":"Long short-term memory algorithm for personalized tacrolimus dosing: A simple and effective time series forecasting approach post-lung transplantation.","authors":"Haruki Choshi, Kentaroh Miyoshi, Maki Tanioka, Hayato Arai, Shin Tanaka, Kazuhiko Shien, Ken Suzawa, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka","doi":"10.1016/j.healun.2024.10.026","DOIUrl":"10.1016/j.healun.2024.10.026","url":null,"abstract":"<p><strong>Background: </strong>Management of tacrolimus trough levels (TTLs) influences morbidity and mortality after lung transplantation. Several studies have explored pharmacokinetic and artificial intelligence models to monitor tacrolimus levels. However, many models depend on a wide range of variables, some of which, like genetic polymorphisms, are not commonly tested for in regular clinical practice. This study aimed to verify the efficacy of a novel approach simply utilizing time series data of tacrolimus dosing, with the objective of accurately predicting trough levels in a variety of clinical settings.</p><p><strong>Methods: </strong>Data encompassing 36 clinical variables for each patient were gathered, and a multivariate long short-term memory algorithm was applied to forecast subsequent TTLs based on the selected clinical variables. The tool was developed using a dataset of 87,112 data points from 117 patients, and its efficacy was confirmed using 6 additional cases.</p><p><strong>Results: </strong>Shapley additive explanations revealed a significant correlation between trough levels and prior dose-concentration data. By using simple trend learning of dose, administration route, and previous trough levels of tacrolimus, we could predict values within 30% of the actual values for 88.5% of time points, which facilitated the creation of a tool for simulating TTLs in response to dosage adjustments. The tool exhibited the potential for rectifying clinical misjudgments in a simulation cohort.</p><p><strong>Conclusions: </strong>Utilizing our time series forecasting tool, precise prediction of trough levels is attainable independently of other clinical variables through the analysis of historical tacrolimus dose-concentration trends alone.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Could emulated trials play a key role in cardiogenic shock trials? 模拟试验能否在心源性休克试验中发挥关键作用?
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-11-04 DOI: 10.1016/j.healun.2024.10.025
Aurore Ughetto, Nicolas Nagot, Clément Delmas
{"title":"Could emulated trials play a key role in cardiogenic shock trials?","authors":"Aurore Ughetto, Nicolas Nagot, Clément Delmas","doi":"10.1016/j.healun.2024.10.025","DOIUrl":"10.1016/j.healun.2024.10.025","url":null,"abstract":"<p><p>Temporary mechanical circulatory support (tMCS) using extracorporeal life support (ECLS), has been widely implemented in patients with cardiogenic shock (CS), although evidence regarding its efficacy and safety remains unclear. This lack of clarity has recently raised concerns about the role of tMCS in CS management. Conducting randomized controlled trials (RCTs) in the context of CS poses significant challenges due to ethical considerations and logistical complexities. In response to these challenges, emulated trials (ETs) are emerging as a promising alternative. By incorporating design features from idealized RCTs, they use robust and rigorous methods to assess the efficacy and safety of health interventions in real-life settings, using observational data. In our manuscript, we highlight the complementary nature of RCT and ETs by evaluating tMCS for CS patients. While RCTs follow a rigorous experimental design and provide reliable evidence, ETs can swiftly estimate the risk-benefit ratio without encountering logistical barriers thereby offering clinicians' early reassurance about the potential benefits of routinely used interventions. Furthermore, ETs offer potential value in unethical situations (refractory cardiac arrest or \"crash and burn\" CS) where interventional therapies, such as tMCS, are used as a last resort.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Donor age and ischemic time in heart transplantation - implications for organ preservation. 心脏移植中的供体年龄和缺血时间--对器官保存的影响。
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-11-02 DOI: 10.1016/j.healun.2024.10.030
Victoria Jernryd, Josef Stehlik, Carsten Metzsch, Lars H Lund, J Gustav Smith, Bodil Andersson, Raquel Perez, Johan Nilsson
{"title":"Donor age and ischemic time in heart transplantation - implications for organ preservation.","authors":"Victoria Jernryd, Josef Stehlik, Carsten Metzsch, Lars H Lund, J Gustav Smith, Bodil Andersson, Raquel Perez, Johan Nilsson","doi":"10.1016/j.healun.2024.10.030","DOIUrl":"10.1016/j.healun.2024.10.030","url":null,"abstract":"<p><strong>Background: </strong>The Organ Care System and Non-ischemic Heart Preservation methods have emerged as significant advancements in heart transplantation, designed to mitigate ischemic injury and extend preservation times. However, their high costs and logistical complexities necessitate strategic utilization.</p><p><strong>Methods: </strong>We evaluated data from 83,761 heart transplants registered in the International Society for Heart and Lung Transplantation registry from 1988 to 2018. Utilizing a Cox proportional hazards model, we explored the influence of donor age and ischemic time on transplant survival. A key innovation of our study is the development of a nomogram to predict post-transplant survival, incorporating both traditional and advanced statistical methods.</p><p><strong>Results: </strong>The median age of recipients was 52 years (22% female) and 33 years (31% female) for donors. Analysis revealed a median ischemic time of 3 hours and median survival of 11.5 years across the cohort. The nomogram showed a decline in survival probabilities with increasing donor age, notably from age 40 and more significantly with ischemic times >4 hours. Ischemic times ≥4 hours versus <2 hours were associated with hazard ratio (HR) of 1.2 (95% CI, 1.1-1.3) for donors aged 40-59, a disparity that escalated for donors aged ≥60 (HR: 2.0; 95% CI, 1.5-2.7).</p><p><strong>Conclusions: </strong>This study highlights the importance of careful donor selection and indicates that certain groups, particularly older donors with prolonged ischemic times, might benefit from ex-vivo preservation techniques. The developed nomogram offers a practical tool for clinicians, enhancing decision-making by providing detailed insights into the relationship between donor age, ischemic time, and post-transplant mortality.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The balance of risks: Outcomes associated with mechanical circulatory support after pediatric heart transplant. 风险的平衡:小儿心脏移植后机械循环支持的相关结果。
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-11-02 DOI: 10.1016/j.healun.2024.10.024
Hari Tunuguntla, Aamir Jeewa
{"title":"The balance of risks: Outcomes associated with mechanical circulatory support after pediatric heart transplant.","authors":"Hari Tunuguntla, Aamir Jeewa","doi":"10.1016/j.healun.2024.10.024","DOIUrl":"10.1016/j.healun.2024.10.024","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early single-center experience with an ex vivo organ care system in pediatric heart transplantation. 在小儿心脏移植手术中使用体内器官护理系统的早期单中心经验。
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-11-01 DOI: 10.1016/j.healun.2024.10.027
Cathlyn K Medina, Berk Aykut, Lauren E Parker, Neel K Prabhu, Lillian Kang, Ziv Beckerman, Jacob N Schroder, Douglas M Overbey, Joseph W Turek
{"title":"Early single-center experience with an ex vivo organ care system in pediatric heart transplantation.","authors":"Cathlyn K Medina, Berk Aykut, Lauren E Parker, Neel K Prabhu, Lillian Kang, Ziv Beckerman, Jacob N Schroder, Douglas M Overbey, Joseph W Turek","doi":"10.1016/j.healun.2024.10.027","DOIUrl":"10.1016/j.healun.2024.10.027","url":null,"abstract":"<p><p>Pediatric heart transplantation (HTx) faces challenges such as limited donor availability and the need for complex reconstructions, particularly in patients with congenital anomalies. Ex vivo perfusion offers a promising approach to minimize graft ischemic time and potentially expand the donor pool. We report our single-center experience using the TransMedics Organ Care System (OCS) for ex vivo perfusion in pediatric HTx. From 2020 to 2024, 8 pediatric patients received OCS-perfused donor hearts. The median recipient age was 13 years (range 9-18), and the median weight was 58.8 kg (33.2-127.8). Indications for HTx included dilated cardiomyopathy (n = 4), hypertrophic cardiomyopathy (n = 1), graft vasculopathy (n = 1), and Fontan failure (n = 2). Median OCS time was 273 minutes (195-328), and recipient ischemic time was 85 minutes (64-139). Post-transplant, all patients had normal LV function at discharge. Over a median follow-up of 11.9 months, there were no deaths. These findings suggest that ex vivo perfusion is a valuable technique in pediatric HTx.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of rewarming ischemia on tissue transcriptome and metabolome signatures: A clinical observational study in lung transplantation. 复温缺血对组织转录组和代谢组特征的影响:肺移植临床观察研究。
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-10-30 DOI: 10.1016/j.healun.2024.10.020
Jan Van Slambrouck, Shauni Loopmans, Elena Prisciandaro, Annalisa Barbarossa, Phéline Kortleven, Simon Feys, Christelle M Vandervelde, Xin Jin, Ismail Cenik, Karen Moermans, Steffen Fieuws, An-Lies Provoost, Anton Willems, Paul De Leyn, Hans Van Veer, Lieven Depypere, Yanina Jansen, Jacques Pirenne, Arne Neyrinck, Birgit Weynand, Bart Vanaudenaerde, Geert Carmeliet, Robin Vos, Dirk Van Raemdonck, Bart Ghesquière, Johan Van Weyenbergh, Laurens J Ceulemans
{"title":"The effect of rewarming ischemia on tissue transcriptome and metabolome signatures: A clinical observational study in lung transplantation.","authors":"Jan Van Slambrouck, Shauni Loopmans, Elena Prisciandaro, Annalisa Barbarossa, Phéline Kortleven, Simon Feys, Christelle M Vandervelde, Xin Jin, Ismail Cenik, Karen Moermans, Steffen Fieuws, An-Lies Provoost, Anton Willems, Paul De Leyn, Hans Van Veer, Lieven Depypere, Yanina Jansen, Jacques Pirenne, Arne Neyrinck, Birgit Weynand, Bart Vanaudenaerde, Geert Carmeliet, Robin Vos, Dirk Van Raemdonck, Bart Ghesquière, Johan Van Weyenbergh, Laurens J Ceulemans","doi":"10.1016/j.healun.2024.10.020","DOIUrl":"10.1016/j.healun.2024.10.020","url":null,"abstract":"<p><strong>Background: </strong>In lung transplantation (LuTx), various ischemic phases exist, yet the rewarming ischemia time (RIT) during implantation has often been overlooked. During RIT, lungs are deflated and exposed to the body temperature in the recipient's chest cavity. Our prior clinical findings demonstrated that prolonged RIT increases the risk of primary graft dysfunction. However, the molecular mechanisms of rewarming ischemic injury in this context remain unexplored. We aimed to characterize the rewarming ischemia phase during LuTx by measuring organ temperature and comparing transcriptome and metabolome profiles in tissue obtained at the end versus the start of implantation.</p><p><strong>Methods: </strong>In a clinical observational study, 34 double-LuTx with ice preservation were analyzed. Lung core and surface temperature (n = 65 and 55 lungs) were measured during implantation. Biopsies (n = 59 lungs) were wedged from right middle lobe and left lingula at start and end of implantation. Tissue transcriptomic and metabolomic profiling were performed.</p><p><strong>Results: </strong>Temperature increased rapidly during implantation, reaching core/surface temperatures of 21.5°C/25.4°C within 30 minutes. Transcriptomics showed increased proinflammatory signaling and oxidative stress at the end of implantation. Upregulation of NLRP3 and NFKB1 correlated with RIT. Metabolomics indicated elevated levels of amino acids, hypoxanthine, uric acid, and cysteineglutathione disulfide alongside decreased levels of glucose and carnitines. Arginine, tyrosine, and 1-carboxyethylleucine showed a correlation with incremental RIT.</p><p><strong>Conclusions: </strong>The final rewarming ischemia phase in LuTx involves rapid organ rewarming, accompanied by transcriptomic and metabolomic changes indicating proinflammatory signaling and disturbed cell metabolism. Limiting implantation time and cooling of the lung represent potential interventions to alleviate rewarming ischemic injury.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization and outcomes of nonintubated extracorporeal membrane oxygenation as a bridge to lung transplant. 无插管体外膜肺氧合作为肺移植桥梁的使用情况和结果。
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-10-30 DOI: 10.1016/j.healun.2024.10.021
Alice L Zhou, Maria R Jennings, Armaan F Akbar, Jessica M Ruck, Atharv Oak, Andrew Kalra, Emily L Larson, Alfred J Casillan, Jinny S Ha, Christian A Merlo, Errol L Bush
{"title":"Utilization and outcomes of nonintubated extracorporeal membrane oxygenation as a bridge to lung transplant.","authors":"Alice L Zhou, Maria R Jennings, Armaan F Akbar, Jessica M Ruck, Atharv Oak, Andrew Kalra, Emily L Larson, Alfred J Casillan, Jinny S Ha, Christian A Merlo, Errol L Bush","doi":"10.1016/j.healun.2024.10.021","DOIUrl":"10.1016/j.healun.2024.10.021","url":null,"abstract":"<p><strong>Background: </strong>Nonintubated extracorporeal membrane oxygenation (ECMO) has been increasingly utilized for patients with severe respiratory failure. Since data on its use as a bridge to lung transplant remain limited, we evaluated its use in a national cohort.</p><p><strong>Methods: </strong>Adult lung-only transplant recipients bridged with ECMO May 4, 2005 to March 8, 2023 in the United Network for Organ Sharing database were categorized by use of ECMO and mechanical ventilation (MV) at transplant (ECMO+MV vs ECMO-only). We compared post-transplant intubation and ECMO at 72 hours, length of stay, and survival.</p><p><strong>Results: </strong>The 1,599 transplants identified included 902 (56.4%) bridged with ECMO+MV and 697 (43.6%) bridged with ECMO-only. ECMO-only recipients had higher median age (52 vs 49 years, p < 0.001), shorter ischemic times (5.7 vs 6.0 hours, p = 0.003), and similar lung allocation scores (89.5 vs 89.6, p = 0.11). ECMO-only recipients had lower likelihood of intubation at 72 hours (56.5% vs 77.5%; adjusted odds ratio 0.33 [95% confidence interval (CI): 0.25, 0.42], p < 0.001) and shorter lengths of stay (28 vs 35 days; coefficient -0.19 [95% CI: -0.27, -0.11], p < 0.001). ECMO-only recipients had higher 90-day survival (92.1% vs 89.1%; adjusted hazards ratio (aHR) 0.69 [95% CI: 0.48, 0.99], p = 0.04) but similar 1-year (83.1% vs 81.5%; aHR 0.87 [95% CI: 0.67, 1.12], p = 0.27) and 5-year (54.6% vs 54.7%; aHR 0.98 [95% CI: 0.82, 1.17], p = 0.83) survival.</p><p><strong>Conclusions: </strong>Nonintubated ECMO bridge to lung transplant was associated with improved perioperative outcomes and short-term survival and should be considered for candidates requiring ECMO.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer as an independent mortality risk in chronic thromboembolic pulmonary hypertension. 癌症是慢性血栓栓塞性肺动脉高压的独立死亡风险。
IF 5.3 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-10-30 DOI: 10.1016/j.healun.2024.10.022
Junichi Nakamura, Ichizo Tsujino, Kohei Masaki, Kazuya Hosokawa, Kouta Funakoshi, Yu Taniguchi, Shiro Adachi, Takumi Inami, Jun Yamashita, Hitoshi Ogino, Masaru Hatano, Nobuhiro Yaoita, Nobutaka Ikeda, Hiroto Shimokawahara, Nobuhiro Tanabe, Kayoko Kubota, Ayako Shigeta, Yoshito Ogihara, Koshin Horimoto, Yoshihiro Dohi, Takashi Kawakami, Yuichi Tamura, Koichiro Tatsumi, Kohtaro Abe
{"title":"Cancer as an independent mortality risk in chronic thromboembolic pulmonary hypertension.","authors":"Junichi Nakamura, Ichizo Tsujino, Kohei Masaki, Kazuya Hosokawa, Kouta Funakoshi, Yu Taniguchi, Shiro Adachi, Takumi Inami, Jun Yamashita, Hitoshi Ogino, Masaru Hatano, Nobuhiro Yaoita, Nobutaka Ikeda, Hiroto Shimokawahara, Nobuhiro Tanabe, Kayoko Kubota, Ayako Shigeta, Yoshito Ogihara, Koshin Horimoto, Yoshihiro Dohi, Takashi Kawakami, Yuichi Tamura, Koichiro Tatsumi, Kohtaro Abe","doi":"10.1016/j.healun.2024.10.022","DOIUrl":"10.1016/j.healun.2024.10.022","url":null,"abstract":"<p><strong>Background: </strong>The management of chronic thromboembolic pulmonary hypertension (CTEPH) has advanced significantly in recent years, thereby improving patient prognosis. However, the impact of cancer on the outcomes of patients with CTEPH under current treatment remains unclear. This study aimed to investigate the prevalence of cancer in patients with CTEPH and determine how comorbid cancer affects their prognosis and clinical course.</p><p><strong>Methods: </strong>Data from an ongoing Japanese prospective cohort study were analyzed. Prevalence and primary cancer sites were evaluated. The association of a history of cancer with a composite endpoint, including all-cause death, lung transplantation, and worsening of CTEPH, as well as venous thromboembolism and bleeding events, was assessed.</p><p><strong>Results: </strong>Of the 1,270 patients in the cohort, 134 (10.6%) had a history of cancer, with the most common primary sites being the breast in women and the prostate in men. The incidence of composite outcome and all-cause death was higher in those with a history of cancer (p < 0.001, log-rank test). In the Cox proportional hazard model, age- and sex-adjusted hazard ratios for the composite outcome and all-cause death were 2.69 (95% confidence interval, 1.48-4.89, p = 0.001) and 4.25 (95% confidence interval, 1.98-9.10, p < 0.001), respectively, for patients with a history of cancer. No significant differences in venous thromboembolism and bleeding events were observed between patients with and those without a history of cancer.</p><p><strong>Conclusions: </strong>A history of cancer, with a prevalence of 10.6%, is an independent risk factor for mortality in patients with CTEPH undergoing the currently recommended treatment.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung transplant pathology: No longer through a glass darkly? 肺移植病理学:不再 "隔岸观火"?
IF 6.4 1区 医学
Journal of Heart and Lung Transplantation Pub Date : 2024-10-28 DOI: 10.1016/j.healun.2024.10.017
Allan R Glanville
{"title":"Lung transplant pathology: No longer through a glass darkly?","authors":"Allan R Glanville","doi":"10.1016/j.healun.2024.10.017","DOIUrl":"10.1016/j.healun.2024.10.017","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信